IDH1 and IDH2 hotspot mutations are not
β
Zachary J. Reitman; Natasha J. Olby; Christopher L. Mariani; Rachael Thomas; Mat
π
Article
π
2009
π
John Wiley and Sons
π
French
β 101 KB
With great interest, we read the recent publication ''CD44positive cells are responsible for gemcitabine resistance in pancreatic cancer cells'' by Hong et al. 1 In this study, the authors established gemcitabine-resistant pancreatic cancer cells in vitro and characterized them in various ways, in v